» Articles » PMID: 37842638

AI/ML Combined with Next-generation Sequencing of VHH Immune Repertoires Enables the Rapid Identification of Humanized and Sequence-optimized Single Domain Antibodies: a Prospective Case Study

Abstract

In this study, we demonstrate the feasibility of yeast surface display (YSD) and nextgeneration sequencing (NGS) in combination with artificial intelligence and machine learning methods (AI/ML) for the identification of de novo humanized single domain antibodies (sdAbs) with favorable early developability profiles. The display library was derived from a novel approach, in which VHH-based CDR3 regions obtained from a llama (Lama glama), immunized against NKp46, were grafted onto a humanized VHH backbone library that was diversified in CDR1 and CDR2. Following NGS analysis of sequence pools from two rounds of fluorescence-activated cell sorting we focused on four sequence clusters based on NGS frequency and enrichment analysis as well as in silico developability assessment. For each cluster, long short-term memory (LSTM) based deep generative models were trained and used for the in silico sampling of new sequences. Sequences were subjected to sequence- and structure-based in silico developability assessment to select a set of less than 10 sequences per cluster for production. As demonstrated by binding kinetics and early developability assessment, this procedure represents a general strategy for the rapid and efficient design of potent and automatically humanized sdAb hits from screening selections with favorable early developability profiles.

Citing Articles

Quantifying antibody binding: techniques and therapeutic implications.

Lodge J, Kajtar L, Duxbury R, Hall D, Burley G, Cordy J MAbs. 2025; 17(1):2459795.

PMID: 39957177 PMC: 11834528. DOI: 10.1080/19420862.2025.2459795.


Development of FAP-targeted theranostics discovered by next-generation sequencing-augmented mining of a novel immunized VNAR library.

Gunaratne G, Gallant J, Ott K, Broome P, Celada S, West J bioRxiv. 2025; .

PMID: 39868181 PMC: 11761682. DOI: 10.1101/2025.01.13.632555.


Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years.

Alexander E, Leong K J Nanobiotechnology. 2024; 22(1):661.

PMID: 39455963 PMC: 11515141. DOI: 10.1186/s12951-024-02900-y.


Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects.

Slavny P, Hegde M, Doerner A, Parthiban K, McCafferty J, Zielonka S Front Immunol. 2024; 15:1469329.

PMID: 39381002 PMC: 11459229. DOI: 10.3389/fimmu.2024.1469329.


A comprehensive overview of recent advances in generative models for antibodies.

Meng F, Zhou N, Hu G, Liu R, Zhang Y, Jing M Comput Struct Biotechnol J. 2024; 23:2648-2660.

PMID: 39027650 PMC: 11254834. DOI: 10.1016/j.csbj.2024.06.016.


References
1.
Saka K, Kakuzaki T, Metsugi S, Kashiwagi D, Yoshida K, Wada M . Antibody design using LSTM based deep generative model from phage display library for affinity maturation. Sci Rep. 2021; 11(1):5852. PMC: 7955064. DOI: 10.1038/s41598-021-85274-7. View

2.
Custers R, Steyaert J . Discussions on the quality of antibodies are no reason to ban animal immunization. EMBO Rep. 2020; 21(12):e51761. PMC: 7726777. DOI: 10.15252/embr.202051761. View

3.
Vincke C, Loris R, Saerens D, Martinez-Rodriguez S, Muyldermans S, Conrath K . General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. J Biol Chem. 2008; 284(5):3273-3284. DOI: 10.1074/jbc.M806889200. View

4.
Nowak C, Cheung J, M Dellatore S, Katiyar A, Bhat R, Sun J . Forced degradation of recombinant monoclonal antibodies: A practical guide. MAbs. 2017; 9(8):1217-1230. PMC: 5680805. DOI: 10.1080/19420862.2017.1368602. View

5.
Jin W, Xing Z, Song Y, Huang C, Xu X, Ghose S . Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification. MAbs. 2019; 11(8):1479-1491. PMC: 6816434. DOI: 10.1080/19420862.2019.1658493. View